 |
CAPSTONE: An Exagen PodcastAuthor: Exagen Podcast
The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove? Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler OMalley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers. Language: en Genres: Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Episode 4: The Questions
Episode 4
Wednesday, 6 July, 2022
What are the highlights surrounding the CAPSTONE study? How does it prove that AVISE testing is improving the diagnostic odyssey? Join Dr. Debra Zack and Tyler O’Malley as they summarize the discoveries of the CAPSTONE study, highlight the key components, and expand on their thoughts on what this means for the future of lupus—and autoimmune—diagnostics.
